Microsatellite instability and the association with plasma homocysteine and thymidylate synthase in colorectal cancer

Cancer Investigation

Volumn 26, Issue 6, 2008, Pages 583-589

  Jensen, Lars Henrik ^a,b   Lindebjerg, Jan ^a   Cruger, Dorthe Gylling ^a   Brandslund, Ivan ^a   Jakobsen, Anders ^a   Kolvraa, Steen ^a   Nielsen, Jens Nederby ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Colorectal cancer; Homocysteine; Methylation; Microsatellite instability; Thymidylate synthase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CARCINOEMBRYONIC ANTIGEN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; THYMIDYLATE SYNTHASE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; COLORECTAL CANCER; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICROSATELLITE INSTABILITY; MIDDLE AGED; NUCLEAR PROTEINS; NUTRITIONAL STATUS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); THYMIDYLATE SYNTHASE;

EID: 46349096806     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900801970992     Document Type: Article

References (36)

1. Popat, S.; Hubner, R.; Houlston, R.S. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005, 23 (3), 609-618.
2. Ribic, C.M.; Sargent, D.J.; Moore, M.J.; Thibodeau, S.N.; French, A.J.; Goldberg, R.M.; Hamilton, S.R.; Laurent-Puig, P.; Gryfe, R.; Shepherd, L.E.; Tu, D.; Redston, M.; Gallinger, S. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003, 349 (3), 247-257.
3. Lanza, G.; Gafa, R.; Santmi, A.; Maestri, !.; Guerzoni, L.; Cavazzini, L. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 2006, 24 (15), 2359-2367.
4. Jover, R.; Zapater, P.; Castells, A.; Llor, X.; Andreu, M.; Cubiella, J.; Pinol, V.; Xicola, R.M.; Bujanda, L.; Rene, J.M.; Clofent, J.; Bessa, X.; Morillas, J.D.; Nicolas-Perez, D.; Paya, A.; Alenda, C. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006, 55 (6), 848-855.
5. Toyota, M.; Ahuja, N.; Ohe-Toyota, M.; Herman, J.G.; Baylin, S.B.; Issa, J.P. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999, 96 (15), 8681-8686.
6. Herman, J.G.; Umar, A.; Polyak, K.; GraffJ.R.; Ahuja, N.; Issa, J.P.; Markowitz, S.; Willson, J.K.; Hamilton, S.R.; Kinzler, K.W.; Kane, M.F.; Kolodner, R.D.; Vogelstein, B.; Kunkel, T.A.; Baylin, S.B. Incidence and functional consequences of hMLH1 promoterhypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998, 95 (12), 6870-6875.
7. Yi, P.; Melnyk, S.; Pogribna, M.; Pogribny, I.P.; Hine, RJ.; James, SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000, 275 (38), 29318-29323.
8. Trinh, B.N.; Ong, C.N.; Coetzee, G.A.; Yu, M.C.; Laird, P.W. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 2002, 111 (3), 299-302.
9. Pufulete, M.; Al Ghnaniem, R.; Rennie, J.A.; Appleby, P.; Harris, N.; Gout, S.; Emery, P.W.; Sanders, T.A. Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer. Br J Cancer 2005, 92 (5), 838-842.
10. Jones, P.A.; Laird, P.W. Cancer epigenetics comes of age. Nat Genet 1999, 21 (2), 163-167.
11. Tran, R.; Kashmiri, S.V.; Kantor, J.; Greiner, J.W.; Pestka, S.; Shively, J.E.; Schlom, J. Correlation of DNA hypomethylation with expression of carcinoembryonic antigen in human colon carcinoma cells. Cancer Res 1988, 48 (20), 5674-5679.
12. Locker, G.Y.; Hamilton, S.; Harris, J.; Jessup, J.M.; Kemeny, N.; Macdonald, J.S.; Somerfield, M.R.; Hayes, D.F.; Bast, R.C., Jr. ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastro intestinal Cancer. J Clin Oncol 2006, 24 (33), 5313-5327.
13. Magera, M.J.; Lacey, J.M.; Casetta, B.; Rinaldo, P. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 1999, 45 (9), 1517-1522.
14. Jensen, L.H.; Cruger, D.C.; Lindeberg, J.; Byriel, L.; Petersen, G.B.; Jakobsen, A. Laser micro dissection and micro satellite analysis of colorectal adenocarcinomas. Anticancer Res 2006, 26, 2069-2074.
15. Grady, W.M.; Rajput, A.; Lutterbaugh, J.D.; Markowitz, S.D. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with micro satellite unstable colon cancer. Cancer Res 2001, 61 (3), 900-902.
16. Iacopetta, B.; Grieu, F.; Joseph, D.; Elsaleh, H. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer 2001, 85 (6), 827-830.
17. Frosst, P.; Blom, H.J.; Milos, R.; Goyette, P.; Sheppard, C.A.; Matthews, R.G.; Boers, GJ.; denHeijer, M.; Kluijtmans, L.A.; van den Heuvel, L.P. A candidate genetic risk factor forvascular disease: a commonmutation in methylene tetrahydrofolate reductase. Nat Genet 1995, 10 (1), 111-113.
18. Lindebjerg, J.; Nielsen, J.N.; Hoeffding, L.D.; Jakobsen, A. Immunohistochemical expression ofthymidylate synthase as predictor of response to capecitabine in patients with advanced colorectal adenocarcinoma. APMIS 2005, 113 (9), 600-602.
19. Matsuzaki, K.; Deng, G.; Tanaka, H.; Kakar, S.; Miura, S.; Kim, Y.S. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin Cancer Res 2005, 11 (24 Pt 1), 8564-8569.
20. Ricciardiell, O.L.; Ceccarelli, C.; Angiolini, G.; Pariali, M.; Chieco, P.; Paterini, P.; Biasco, G.; Martinelli, G.N.; Roda, E.; Bazzoli, F. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies. Clin Cancer Res 2005, 11 (11), 4234-4240.
21. Okon, K.; Klimkowska, A.; Wojcik, P.; Osuch, C.; Papla, B.; Stachura, J. High thymidylate synthase expression is typical for sporadic MSI-H colorectal carcinoma. Pol J Pathol 2006, 57 (1), 29-33.
22. Popat, S.; Wort, R.; Houlston, R.S. Inter-relationship between micro satellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance. BMC Cancer 2006, 6, 150.
23. Sinicrope, F.A.; Rego, R.L.; Halling, K.C.; Foster, N.R.; Sargent, D.J.; La Plant, B.; French, AJ.; Allegra, C.J.; Laurie, J.A.; Goldberg, R.M.; Witzig, T.E.; Thibodeau, S.N. Thymidylate synthase expression in colon carcinomas with micro satellite instability. Clin Cancer Res 2006, 12 (9), 2738-2744.
24. Food Standards: Amendment of Standards of Identity For Enriched Grain Products to Require Addition of Folic Acid. Fed Reg 1998, 61 (44), 8781-8807.
25. Selhub, J.; Jacques, P.F.; Wilson, P.W.; Rush, D.; Rosenberg, I.H. Vitamin status and intake asprimary determinants of homocysteinemia in an elderly population. JAMA 1993, 270 (22), 2693-2698.
26. Meenan, J.; O'Hallinan, E.; Scott, J.; Weir, D.G. Epithelial cell folate depletion occurs in neoplastic but not adjacent normal colon mucosa. Gastroenterol 1997, 112 (4), 1163-1168.
27. Merkelbach-Bruse, S.; Hans, V.; Mathiak, M.; Sanguedolce, R.; Alessandro, R.; Ruschoff, J.; Buttner, R.; Houshdaran, F.; Gullotti, L. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the micro satellite instability phenotype of colorectal cancer. Oncol Rep 2004, 11 (4), 839-843.
28. Calascibetta, A.; Cabibi, D.; Martorana, A.; Sanguedolce, G.; Rausa, L.; Feo, S.; Dardanoni, G.; Sanguedolce, R. Thymidylate synthase gene promoter polymorphisms are associated with TSm-RNA expressions but not with micro satellite instability in colorectal cancer. Anticancer Res 2004, 24 (6), 3875-3880.
29. Narayanan, S.; McConnell, J.; Little, J.; Sharp, L.; Piyathilake, C.J.; Powers, H.; Basten, G.; Duthie, SJ. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev 2004, 13 (9), 1436-1443.
30. Shannon, B.; Gnanasampanthan, S.; Beilby, J.; Iacopetta, B. A polymorphism in the methylene tetrahydrofolate reductase gene predisposes to colorectal cancers with micro satellite instability. Gut 2002, 50 (4), 520-524.
31. Sharp, L.; Little, J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004, 159 (5), 423-443.
32. Chen, J.; Kyte, C.; Valcin, M.; Chan, W.; Wetmur, J.G.; Selhub, J.; Hunter, D.J.; Ma, J. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int J Cancer 2004, 110 (4), 617-620.
33. Suh, J.H.; Lim, S.D.; Kim, J.C.; Hong, S.H.; Kang, G.H. Comparison of clinicopathologic characteristics and genetic alterations between microsatellite instability-positive and microsatellite instability-negative sporadic colorectal carcinomas in patients younger than 40 years old. Dis Colon Rectum 2002, 45 (2), 219-228.
34. Popat, S.; Matakidou, A.; Houlston, R.S. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 2004, 22 (3), 529-536.
35. Longley, D.B.; Harkin, D.P.; Johnston, P.G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003, 3 (5), 330-338.
36. Jakobsen, A.; Nielsen, J.N.; Gyldenkerne, N.; Lindeberg, J. Thymidylate synthase and methylene tetrahydrofolate reductase gene polymorphism in normal tissue as predictors of Fluorouracil sensitivity. J Clin Oncol 2005, 23 (7), 1365-1369.